| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| FRESH2 GROUP Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 31,700 | +1,54 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| TELADOC HEALTH | 7,920 | -1,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| BICO GROUP | 1,690 | -25,06 % | BICO Group AB: Announcing the BICO 2030 Strategy and changes in Executive Management | BICO launches the BICO 2030 strategy, sharpening the Group's focus on Precision Biology and moving away from the large-scale integrated Lab Automation project business. However, Lab Automation remains... ► Artikel lesen | |
| CERENOME | 0,508 | -12,41 % | Cerenome names Ron Andrews as chief business officer | ||
| MCKESSON | 971,00 | -0,02 % | McKesson Corp. Profit Advances In Q2 | WASHINGTON (dpa-AFX) - McKesson Corp. (MCK) announced earnings for its second quarter that Increases, from last yearThe company's bottom line totaled $1.218 billion, or $10.47 per share. This... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| UNIDOC HEALTH | 0,030 | +0,67 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| NETRAMARK | 0,359 | -2,97 % | NetraMark Holdings Inc.: NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness | TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,289 | 0,00 % | Co-Diagnostics Reports Third Quarter 2026 Financial Results | Two Regulatory Submissions Under Review in India and the U.S. Third Quarter Operating Expenses Down 12% Year Over YearPlatform Capabilities Expanding with ReadyGo Collaboration, India Connectivity and... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 560,00 | +3,70 % | Aktien KW 36 Iran, Zinsangst und Trump-"unsinn" bremsen - was wäre wenn? News. Rheinmetall. Vonovia. DEFAMA. Smartbroker. Sino. Trade Republic. Limes Schlosskliniken. Mutares. Symrise. Aroundtown. Enapter. Bilfinger. Nagarro. Haier Smart. Delivery Hero | Aktien - diese Woche im Niemandsland. Positiv am Ende der Woche steht wieder 26 am Anafng des DAX, aber Schwung nach oben fehlt. Impulse hätten Nvidia und die anderen Ki-Aktien mit teilweise beeindruckenden... ► Artikel lesen | |
| VERU | 2,140 | +0,94 % | Veru executive to present obesity drug data at industry conference | ||
| CYTOSORBENTS | 5,810 | 0,00 % | Cytosorbents Corp: CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement | PRINCETON, N.J., Sept. 23, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,290 | -2,50 % | Clover Health auf der UBS Global Healthcare Conference: Starkes Wachstum trifft auf steigende Ertragskraft | ||
| VOLITIONRX | 0,188 | 0,00 % | VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, August 14 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Aug. 13, 2026 /PRNewswire/... ► Artikel lesen |